(Q83762288)

English

Baseline anti-citrullinated peptide antibody (ACPA) titers and serum interleukin-6 (IL-6) levels possibly predict progression of bone destruction in early stages of rheumatoid arthritis (ERA)

scientific article published on 29 March 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22457007%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Baseline anti-citrullinated peptide antibody (ACPA) titers and serum interleukin-6 (IL-6) levels possibly predict progression of bone destruction in early stages of rheumatoid arthritis (ERA) (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22457007%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

author name string

Yukihiko Saeki

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22457007%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Eriko Kudo-Tanaka

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22457007%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Shiro Ohshima

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22457007%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Masato Matsushita

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22457007%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

So-ichiro Tsuji

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22457007%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Yu-ichi Maeda

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22457007%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Maiko Yoshimura

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22457007%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Akane Watanabe

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22457007%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Yoshinori Katada

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22457007%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Yoshinori Harada

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22457007%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Kenji Ichikawa

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22457007%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Yasuo Suenaga

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22457007%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Yusuke Ohta

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22457007%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Shigeto Tohma

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22457007%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

NHO iR-net Study Group

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22457007%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

publication date

29 March 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22457007%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Rheumatology International

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22457007%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

33

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22457007%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22457007%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

451-456

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22457007%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

https://scigraph.springernature.com/pub.10.1007/s00296-012-2397-1

0 references

The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22457007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines for the management of rheumatoid arthritis: 2002 Update

1 reference

https://pubmed.ncbi.nlm.nih.gov/22457007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rheumatoid arthritis: treatment which controls the C-reactive protein and erythrocyte sedimentation rate reduces radiological progression

1 reference

https://pubmed.ncbi.nlm.nih.gov/22457007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22457007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic criteria in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22457007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum MMP-3 and MMP-1 and progression of joint damage in early rheumatoid arthritis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22457007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autoantibodies to cyclic citrullinated peptide 2 (CCP2) are superior to other potential diagnostic biomarkers for predicting rheumatoid arthritis in early undifferentiated arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22457007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Agalactosyl IgG: an aid to differential diagnosis in early synovitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22457007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Two year randomized controlled trial of etidronate in rheumatoid arthritis: changes in serum aminoterminal telopeptides correlate with radiographic progression of disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/22457007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IL-6 and IL-1 synergistically enhanced the production of MMPs from synovial cells by up-regulating IL-6 production and IL-1 receptor I expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/22457007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22457007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin 6: from bench to bedside

1 reference

https://pubmed.ncbi.nlm.nih.gov/22457007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22457007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biomarkers in early rheumatoid arthritis: longitudinal associations with inflammation and joint destruction measured by magnetic resonance imaging and conventional radiographs

1 reference

https://pubmed.ncbi.nlm.nih.gov/22457007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The therapeutic approach of early intervention for rheumatoid arthritis: what is the evidence?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22457007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22457007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term follow-up of the changes in circulating cytokines, soluble cytokine receptors, and white blood cell subset counts in patients with rheumatoid arthritis (RA) after monoclonal anti-TNF alpha antibody therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22457007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anticitrullinated protein/peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22457007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q83762288&oldid=2034945012"